COLD-PCR Enrichment of Rare Cancer Mutations prior to Targeted Amplicon Resequencing

Coren A. Milbury, Mick Correll, John Quackenbush, Renee Rubio, G. Mike MakrigiorgosClinical 2011 · DOI

Abstract

As cancer care shifts toward personalized intervention based on each patient's unique genetic abnormalities and tumor genome, we anticipate that COLD-PCR combined with NGS will elucidate the role of mutations in tumor progression, enabling NGS-based analysis of diverse clinical specimens within clinical practice.
BibTeX
@inproceedings{milbury2011cold,
  author = {Coren A. Milbury and Mick Correll and John Quackenbush and Renee Rubio and G. Mike Makrigiorgos},
  title = {{COLD-PCR Enrichment of Rare Cancer Mutations prior to Targeted Amplicon Resequencing}},
  booktitle = {Clinical},
  year = {2011},
  doi = {10.1373/clinchem.2011.176198},
}

Loading related content...

Figure